Twist Bioscience Corp
Research Twist Bioscience Corp (TWST) on Bullrun: market cap USD 9.49B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTWST
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Market capUSD 9.49B
- Financial periodQ2 2026
- RevenueUSD 118.38M
- Net income-USD 35.05M
- Free cash flow-USD 8.65M
- Gross margin52.8%
Valuation Snapshot
latest market cap is USD 9.49B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 376.57M | -USD 77.67M | -USD 75.63M | 50.7% | -1.3 | USD 183.05M | USD 98.05M | USD 472.96M |
| FY2024 | USD 312.97M | -USD 208.73M | -USD 69.17M | 42.6% | -3.6 | USD 226.32M | USD 82.62M | USD 472.69M |
| FY2023 | USD 245.11M | -USD 204.62M | -USD 170.25M | 36.6% | -3.6 | USD 286.47M | USD 91.88M | USD 623.43M |
| FY2022 | USD 203.57M | -USD 217.86M | -USD 226.24M | 41.4% | -4.04 | USD 378.69M | USD 0 | USD 789.39M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 9.49B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 1.94B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 2.77B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 2.13B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 1.35B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 3.93B | n/a | n/a | n/a |
About Twist Bioscience Corp
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Twist Bioscience Corp's market cap?
Twist Bioscience Corp's market capitalization is USD 9.49B.
What does Twist Bioscience Corp do?
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused.